Family-based treatment more effective than supportive psychotherapy in treati...(he six-month follow-up; however the diff...),Health
Navigation Links
Family-based treatment more effective than supportive psychotherapy in treating bulimia
Date:9/3/2007
he six-month follow-up; however, the difference was statistically in favor of family-based treatment vs. supportive psychotherapy (12 patients [29 percent] vs. 4 patients [10 percent]), the authors write.
Results suggest that family-based treatment for bulimia nervosa is promising in the amelioration of symptomatic behavior for this disorder, the authors conclude. However, we do not know whether it is family involvement or the focus on eating behavior that is key to good treatment outcome. Moreover, abstinence rates between 30 percent and 40 percent leave considerable room for improvement.
'/>"/>
| Contact: Scot Roskelley 773-795-0892 JAMA and Archives Journals Source:Eurekalert |
Related medicine news :
1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Thyroid hormone treatment hastens recovery after cardiac surgery
4. Feeding channel created by malaria parasite - a new target for malaria treatments
5. Now umbilical cord helps in stroke treatment.
6. Now AIDS treatment comes dirt-cheap
7. Breast cancer treatment to be determined by gene test
8. Hemopurifier may revolutionise AIDS treatment
9. New drug helps boost cancer treatment
10. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
11. Experimental treatment for Ebola Virus Shows promising results in mice
Post Your Comments:
(Date:12/6/2009)... become a mainstay of multiple myeloma treatment may ... of patients who have received stem cell transplants ... clinical trial results to be presented by ... Society of Hematology,s (ASH) annual meeting on Sunday, ... Center, Room 243-245, 5:45 pm CT). , ...
(Date:12/6/2009)... NEW ORLEANS, Dec. 6 Onyx Pharmaceuticals, ... safety data from the pivotal Phase 2b 003-A1 ... carfilzomib is well-tolerated in heavily pre-treated relapsed and ... today at the ASH/ASCO Joint Symposium at the ... Hematology (ASH) in New Orleans. Enrollment in this ...
(Date:12/6/2009)... the community, in cooperation with the Greater VA Healthcare System in ... year,s attendance is expected to soar to more than 5,000 veterans, ... ... (PRWEB) December 6, 2009 -- Volunteer organizations and members of ... West Los Angeles, will once again create a holiday party. This ...
(Date:12/5/2009)... 5 The first Football,for Hope Centre in ... its doors,today (5 December 2009). FIFA President Joseph ... Zille, 2010 FIFA World Cup Organising Committee,South Africa ... Kirsten Nematandani and Executive Mayor of the City ...
(Date:12/5/2009)... Technology Center helps companies develop and test their cleaning processes. The ... variety of industries and solve problems for customers relating to cleaning ... ... 5, 2009 -- Midbrook, Inc , a Jackson, MI-based company, ...
Breaking Medicine News(10 mins):Health News:Bortezomib shows promise in reducing GVHD and reconstituting immune system in some patients 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3[0] Bortezomib shows promise in reducing GVHD and reconstituting immune system in some patients[1] Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability[0] 17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” [0] Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha[0] Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification
... for the Thanksgiving holiday, a new research report published ... ), may provide some relief for those leery of ... describe a discovery that may allow some obese people ... they make a common antioxidant, melanin, in excess. Even ...
... The American Journal of Nursing (AJN) ... the Caregiver Award is being given to Jean and ... commitment and generosity to nursing. The Award, recognizing ... for nurses and excellence in nursing practice, was presented ...
... John G. Schulte with Chairman ... Emile J. Geisenheimer., ... on behalf of those who purchased Spectranetics Company,stock (Nasdaq: SPNC ... violated U.S. securities laws through illegal,marketing practices and false statements about ...
... and Online Content to Fight,Mental Health Stigma and ... YORK, Oct. 29 mtvU, MTV,s 24-hour college ... to reduce emotional,distress and prevent suicide among college ... campaign with new content launching,today that encourages students ...
... CHERRY HILL, N.J., Oct. 29 TriMix ... flagship product,TriMix-gel(TM). TriMix-gel(TM) uses the ED gel(TM) (pat. ... an adapter to make the use of,TriMix-gel(TM) even ... included,for shipment to patients immediately., The new ...
... HAP offers a free informational DVD and workshops, ... a little easier. During the Medicare Annual Enrollment ... and whether to,select different coverage options. Detroit-based Health ... anyone seeking information about Medicare and,how to approach ...
Other Medicine News:Health News:New drug target in obesity: Fat cells make lots of melanin 2Health News:The American Journal of Nursing honors Jean and Ric Edelman 2Health News:The American Journal of Nursing honors Jean and Ric Edelman 3Health News:Hagens Berman Sobol Shapiro: Class Action Filed Against Spectranetics 2Health News:Hagens Berman Sobol Shapiro: Class Action Filed Against Spectranetics 3Health News:Hagens Berman Sobol Shapiro: Class Action Filed Against Spectranetics 4Health News:mtvU and The Jed Foundation Ask Students 'How Are You A Friend?' 2Health News:mtvU and The Jed Foundation Ask Students 'How Are You A Friend?' 3Health News:mtvU and The Jed Foundation Ask Students 'How Are You A Friend?' 4Health News:mtvU and The Jed Foundation Ask Students 'How Are You A Friend?' 5Health News:mtvU and The Jed Foundation Ask Students 'How Are You A Friend?' 6Health News:For Patients Who Fail on Viagra, Levitra or Cialis 2Health News:For Patients Who Fail on Viagra, Levitra or Cialis 3Health News:Need Help Making Medicare Work for You? 2New drug target in obesity: Fat cells make lots of melaninThe American Journal of Nursing honors Jean and Ric EdelmanHagens Berman Sobol Shapiro: Class Action Filed Against SpectraneticsmtvU and The Jed Foundation Ask Students 'How Are You A Friend?'For Patients Who Fail on Viagra, Levitra or CialisNeed Help Making Medicare Work for You?
(Date:12/4/2009)... 4 AstraZeneca (NYSE: AZN ) today ... has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release ... with Major Depressive Disorder (MDD). SEROQUEL XR is the ... to treat both major depressive disorder as adjunctive therapy ...
(Date:12/3/2009)... , a leading primary research firm, today announced the launch ... that monitors and projects trends and market share in the ... captures actual patient usage for 87 different Sleep Apnea mask ... providers going back to January 2006. In the most ...
(Date:12/3/2009)... and STATE COLLEGE, Pa., Dec. 3 Ambry ... an agreement to provide extended bioinformatics genomics services ... performed at Ambry. ,, (Logo: ... CSO said, "Our team at Ambry has been ...
Breaking Medicine Technology:US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth Personal Emergency Response and Medical Monitoring Syste 57351 1Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth Personal Emergency Response and Medical Monitoring Syste 57351 2Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth Personal Emergency Response and Medical Monitoring Syste 57351 3Sinovac to Present at 2009 UBS Global Life Sciences Conference 14092 1Sinovac to Present at 2009 UBS Global Life Sciences Conference 14092 2How to reach proficiency in laparoscopic splenectomy 3F 57347 1[0] US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder[0] Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker[0] Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects
... plans initiation of clinical studies; Data to be ... 21 Drug discovery and development company Esperance ... preclinical program that support the initiation of ... candidate from the Company,s Cationic Lytic Peptide (CLYP(TM)) ...
... NanoVibronix, a medical device,company specializing in applications ... novel device has received CE approval in ... is the first hands-free,patch-based device that uses ... The innovative PainShield consists of a disposable ...
Other Medicine Technology:First Candidate from Esperance's Targeted Anti-cancer Platform, EP-100, Establishes Preclinical Proof of Concept 2First Candidate from Esperance's Targeted Anti-cancer Platform, EP-100, Establishes Preclinical Proof of Concept 3NanoVibronix Receives Wound Healing Indications in Europe for its PainShield(TM) Device 2... USIOL lenses are manufactured using ... processes. Perspex CQ UV PMMA ... multi-piece and single piece lenses. ... in both nonphaco and phaco ...
Optical implants for the replacement of the human crystalline lens in the visual correction of aphakia....
1% Sodium Hyaluronate, 10mg/mL, sterile opthalmic injection...
... with optimum molecular weight and viscosity, so ... coats and protects the delicate structures of ... balance of cohesion, adhesion, and pseudoplasticity to ... phaco surgeon expects from an ophthalmic viscoelastic ...
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |